274 related articles for article (PubMed ID: 15039226)
1. Advanced glycation end products induce tubular epithelial-myofibroblast transition through the RAGE-ERK1/2 MAP kinase signaling pathway.
Li JH; Wang W; Huang XR; Oldfield M; Schmidt AM; Cooper ME; Lan HY
Am J Pathol; 2004 Apr; 164(4):1389-97. PubMed ID: 15039226
[TBL] [Abstract][Full Text] [Related]
2. Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE).
Oldfield MD; Bach LA; Forbes JM; Nikolic-Paterson D; McRobert A; Thallas V; Atkins RC; Osicka T; Jerums G; Cooper ME
J Clin Invest; 2001 Dec; 108(12):1853-63. PubMed ID: 11748269
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor-beta regulates tubular epithelial-myofibroblast transdifferentiation in vitro.
Fan JM; Ng YY; Hill PA; Nikolic-Paterson DJ; Mu W; Atkins RC; Lan HY
Kidney Int; 1999 Oct; 56(4):1455-67. PubMed ID: 10504497
[TBL] [Abstract][Full Text] [Related]
4. Pravastatin inhibits advanced glycation end products (AGEs)-induced proximal tubular cell apoptosis and injury by reducing receptor for AGEs (RAGE) level.
Ishibashi Y; Yamagishi S; Matsui T; Ohta K; Tanoue R; Takeuchi M; Ueda S; Nakamura K; Okuda S
Metabolism; 2012 Aug; 61(8):1067-72. PubMed ID: 22386936
[TBL] [Abstract][Full Text] [Related]
5. Receptor for advanced glycation end-products promotes premature senescence of proximal tubular epithelial cells via activation of endoplasmic reticulum stress-dependent p21 signaling.
Liu J; Huang K; Cai GY; Chen XM; Yang JR; Lin LR; Yang J; Huo BG; Zhan J; He YN
Cell Signal; 2014 Jan; 26(1):110-21. PubMed ID: 24113348
[TBL] [Abstract][Full Text] [Related]
6. [Effects of induction of tubular epithelial-myofibroblast transition by monocyte chemoattractant protein-1 and mechanism thereof: an in vitro experiment].
Li HL; Zheng FL; Zhao B
Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(6):400-5. PubMed ID: 18581895
[TBL] [Abstract][Full Text] [Related]
7. The protective effect of Smilax glabra extract on advanced glycation end products-induced endothelial dysfunction in HUVECs via RAGE-ERK1/2-NF-κB pathway.
Sang HQ; Gu JF; Yuan JR; Zhang MH; Jia XB; Feng L
J Ethnopharmacol; 2014 Aug; 155(1):785-95. PubMed ID: 24953033
[TBL] [Abstract][Full Text] [Related]
8. Advanced glycation end products induce calcification of vascular smooth muscle cells through RAGE/p38 MAPK.
Tanikawa T; Okada Y; Tanikawa R; Tanaka Y
J Vasc Res; 2009; 46(6):572-80. PubMed ID: 19571577
[TBL] [Abstract][Full Text] [Related]
9. Advanced glycation end-products activate extracellular signal-regulated kinase via the oxidative stress-EGF receptor pathway in renal fibroblasts.
Chen SC; Guh JY; Hwang CC; Chiou SJ; Lin TD; Ko YM; Huang JS; Yang YL; Chuang LY
J Cell Biochem; 2010 Jan; 109(1):38-48. PubMed ID: 19885844
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-1 induces tubular epithelial-myofibroblast transdifferentiation through a transforming growth factor-beta1-dependent mechanism in vitro.
Fan JM; Huang XR; Ng YY; Nikolic-Paterson DJ; Mu W; Atkins RC; Lan HY
Am J Kidney Dis; 2001 Apr; 37(4):820-31. PubMed ID: 11273883
[TBL] [Abstract][Full Text] [Related]
11. Myofibroblast transdifferentiation of mesothelial cells is mediated by RAGE and contributes to peritoneal fibrosis in uraemia.
De Vriese AS; Tilton RG; Mortier S; Lameire NH
Nephrol Dial Transplant; 2006 Sep; 21(9):2549-55. PubMed ID: 16757496
[TBL] [Abstract][Full Text] [Related]
12. AGEs activate mesangial TGF-beta-Smad signaling via an angiotensin II type I receptor interaction.
Fukami K; Ueda S; Yamagishi S; Kato S; Inagaki Y; Takeuchi M; Motomiya Y; Bucala R; Iida S; Tamaki K; Imaizumi T; Cooper ME; Okuda S
Kidney Int; 2004 Dec; 66(6):2137-47. PubMed ID: 15569303
[TBL] [Abstract][Full Text] [Related]
13. Extracellular matrix is modulated in advanced glycation end products milieu via a RAGE receptor dependent pathway boosted by transforming growth factor-β1 RAGE.
Serban AI; Stanca L; Geicu OI; Munteanu MC; Costache M; Dinischiotu A
J Diabetes; 2015 Jan; 7(1):114-24. PubMed ID: 24666836
[TBL] [Abstract][Full Text] [Related]
14. [Interventional effects of emodin on transforming growth factor-beta1/integrin-linked kinase signal way in interleukin-1beta-induced transdifferentiation of rat tubular epithelial-myofibroblasts].
Chen TF; Chen M; Qin JH; Wang MY
Zhong Xi Yi Jie He Xue Bao; 2009 Jan; 7(1):59-64. PubMed ID: 19134459
[TBL] [Abstract][Full Text] [Related]
15. Metformin inhibits advanced glycation end products (AGEs)-induced renal tubular cell injury by suppressing reactive oxygen species generation via reducing receptor for AGEs (RAGE) expression.
Ishibashi Y; Matsui T; Takeuchi M; Yamagishi S
Horm Metab Res; 2012 Nov; 44(12):891-5. PubMed ID: 22864903
[TBL] [Abstract][Full Text] [Related]
16. Irbesartan inhibits advanced glycation end product (AGE)-induced proximal tubular cell injury in vitro by suppressing receptor for AGEs (RAGE) expression.
Matsui T; Yamagishi S; Takeuchi M; Ueda S; Fukami K; Okuda S
Pharmacol Res; 2010 Jan; 61(1):34-9. PubMed ID: 19635564
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of thioredoxin-interacting protein ameliorates high glucose-induced epithelial to mesenchymal transition in renal tubular epithelial cells.
Wei J; Shi Y; Hou Y; Ren Y; Du C; Zhang L; Li Y; Duan H
Cell Signal; 2013 Dec; 25(12):2788-96. PubMed ID: 24041652
[TBL] [Abstract][Full Text] [Related]
18. Advanced glycation end products activate Smad signaling via TGF-beta-dependent and independent mechanisms: implications for diabetic renal and vascular disease.
Li JH; Huang XR; Zhu HJ; Oldfield M; Cooper M; Truong LD; Johnson RJ; Lan HY
FASEB J; 2004 Jan; 18(1):176-8. PubMed ID: 12709399
[TBL] [Abstract][Full Text] [Related]
19. Advanced glycation end-products induce tubular CTGF via TGF-beta-independent Smad3 signaling.
Chung AC; Zhang H; Kong YZ; Tan JJ; Huang XR; Kopp JB; Lan HY
J Am Soc Nephrol; 2010 Feb; 21(2):249-60. PubMed ID: 19959709
[TBL] [Abstract][Full Text] [Related]
20. Advanced glycation end product 3 (AGE3) suppresses the mineralization of mouse stromal ST2 cells and human mesenchymal stem cells by increasing TGF-β expression and secretion.
Notsu M; Yamaguchi T; Okazaki K; Tanaka K; Ogawa N; Kanazawa I; Sugimoto T
Endocrinology; 2014 Jul; 155(7):2402-10. PubMed ID: 24758301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]